MedicarePartD.guide

A non-government resource built from CMS public data

Methylphenidate on HealthSpring Assurance Rx (S5617-215)

Covered.

Tier 3 (preferred brand). Quantity limit of 90 per 30 days.

$3.53
Patient pays / month, after deductible
$16.81
Patient pays / month, before the $615.00 deductible
$10.59
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

METHYLPHENIDATE HYDROCHLORIDE 5 mg Tablet at a preferred retail pharmacy, from the plan's negotiated price of $16.81 for a month. Other covered strengths are listed below.

All 13 covered strengths and forms
FormTierPatient pays / monthLimits
METHYLPHENIDATE HYDROCHLORIDE 10 mg Tablet3$4.6490 per 30 days
METHYLPHENIDATE HYDROCHLORIDE 10 mg Tablet, Extended Release431%None
METHYLPHENIDATE HYDROCHLORIDE 18 mg Tablet, Extended Release431%None
METHYLPHENIDATE HYDROCHLORIDE 18 mg Tablet, Extended Release431%None
METHYLPHENIDATE HYDROCHLORIDE 20 mg Tablet3$6.5290 per 30 days
METHYLPHENIDATE HYDROCHLORIDE 20 mg Tablet, Extended Release431%None
METHYLPHENIDATE HYDROCHLORIDE 27 mg Tablet, Extended Release431%None
METHYLPHENIDATE HYDROCHLORIDE 36 mg Tablet, Extended Release431%None
METHYLPHENIDATE HYDROCHLORIDE 5 mg Tablet3$3.5390 per 30 days
METHYLPHENIDATE HYDROCHLORIDE 54 mg Tablet, Extended Release431%None
METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE 27 mg Tablet, Extended Release431%None
METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE 36 mg Tablet, Extended Release431%None
METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE 54 mg Tablet, Extended Release431%None

Verify with the plan before prescribing or filling. Member services: (800)222-6700. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s5617-215